Skip to main content
. 2015 Jun 15;5(7):2241–2248.

Figure 1.

Figure 1

Correlation of ITF-2B protein levels with survival. (A) (a, b) Cytoplasmic ITF-2B levels in human colorectal carcinomas: 52 (24%) cases displayed no cytoplasmic ITF-2B (a), whereas 161 (76%) showed cytoplasmic ITF-2B (b). (c, d) Intensity of nuclear ITF-2B protein staining in human colorectal carcinomas: 105 cases (49%) showed no or low intensity of nuclear ITF-2B staining (c), whereas 108 cases (51%) displayed high ITF-2B protein levels (d). (Original magnification: 400 ×). (B) Cytoplasmic ITF-2B levels correlated with overall survival. Kaplan-Meier plot of colorectal carcinomas specimens (n=213) demonstrated significant (log-rank test) better survival with cytoplasmic ITF-2B levels (P=0.033). (C) Cytoplasmic ITF-2B levels correlated with progression free survival. Kaplan-Meier plot of colorectal carcinomas specimens demonstrated significant (log-rank test) better survival with cytoplasmic ITF-2B levels (P=0.024).